A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail to Achieve a Complete Response to Initial Gleevec Treatment.
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2011
At a glance
- Drugs Arsenic trioxide (Primary) ; Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 04 Jun 2009 New trial record.